RPAM
AKRO icon

Rhenman & Partners Asset Management’s Akero Therapeutics AKRO Stock Holding History

Rhenman & Partners Asset Management’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$10.5M Buy
197,600
+105,100
+114% +$5.61M 1.33% 31
2025
Q1 		$3.74M Buy
+92,500
New +$3.74M 0.43% 54